Skip to content
PubMed This is a summary of 11 peer-reviewed journal articles Updated
Pediatric Endocrinology

Management and Monitoring: The Road Ahead

At a Glance

Infants born with athyreosis require lifelong levothyroxine treatment starting within the first 14 days of life. Proper medication administration, consistent brand use, and regular blood tests to monitor TSH and Free T4 levels are essential to ensure healthy brain and body development.

Because your baby was born without a thyroid gland, providing a daily source of thyroid hormone is the most important way to support their health. The standard of care for athyreosis is the immediate and lifelong use of levothyroxine (LT4), a synthetic version of the hormone your baby’s body would naturally produce [1][2].

Starting Treatment: The First Two Weeks

Timing is critical. To ensure your baby’s brain and body have the “fuel” they need for rapid newborn development, treatment should ideally begin within the first 14 days of life [3][4].

  • The Dosage Dilemma: Most infants with congenital hypothyroidism start with a dose of 10 to 15 mcg/kg/day [1].
  • Athyreosis Nuance: Interestingly, some research suggests that the highest recommended dose (15 mcg/kg/day) may actually be slightly more than infants with athyreosis need, potentially leading to over-treatment [5]. Your pediatric endocrinologist will carefully “individualize” your baby’s dose to find the perfect balance for their specific body weight and needs [2][6].

The Dangers of “Too Much” or “Too Little”

The goal is to keep thyroid levels in a target healthy range [1].

  • Under-treatment (Levels too low): This can lead to intellectual disabilities, slowed growth, and developmental delays [2][7].
  • Over-treatment (Levels too high): While it might seem like more hormone would be better, levels that are too high can cause heart strain, poor sleep, and issues with bone density over time [8].

How to Give Medication to a Newborn

Giving medication to a newborn can feel intimidating, but establishing a safe routine is crucial. Never put the medication in a full bottle. If the baby does not finish the bottle, they will miss their full dose, risking severe under-treatment.

Here is the safest way to administer levothyroxine:

  1. Crushed Pills: Crush the pill thoroughly between two spoons. Mix the powder with a few drops of water, breastmilk, or non-soy formula on a spoon or in a small oral syringe. Administer the mixture directly into the inside of your baby’s cheek.
  2. Liquid Levothyroxine: Ask your endocrinologist if FDA-approved liquid levothyroxine formulations are available in your region. Many modern pediatric endocrinologists prescribe liquid options, which are easier and safer to measure and give to infants.

Tips for Success at Home

  • Consistency is Key: Give the medication at the same time every day. Try to be consistent with feeding times around the medication dose as well, to keep absorption steady.
  • Avoid Interference: Do not give levothyroxine at the same time as soy formula, iron supplements, or calcium drops, as these can block the medicine from being absorbed into the bloodstream.
  • Stick to One Brand: Different brands of levothyroxine can vary slightly. Once your baby is doing well on one brand, try to stick with it for all future refills.

Monitoring: Your Blood Test Schedule

Because your baby will grow rapidly in the first few years, their need for thyroid hormone will change frequently. Regular blood tests—measuring TSH and Free T4—are the only way to ensure the dosage remains correct [9][10].

According to consensus guidelines, you can generally expect the following monitoring schedule for the first three years [10][11]:

Age of Child Frequency of Blood Tests
First 2 weeks of treatment 1–2 weeks after starting medication
Birth to 6 months Every 1 to 2 months
6 months to 3 years Every 3 months
After 3 years Every 3 to 6 months (until growth is complete)

Additional tests are typically needed 2–4 weeks after any change in the medication dose.

Common questions in this guide

When should levothyroxine treatment start for a baby with athyreosis?
Treatment should ideally begin within the first 14 days of life. Early and consistent treatment provides the essential hormones needed to fuel rapid newborn brain and physical development.
How do I safely give levothyroxine to my newborn?
You can use an FDA-approved liquid formulation or crush the pill thoroughly and mix it with a few drops of water, breastmilk, or non-soy formula. Administer it directly into your baby's cheek using a syringe or spoon, and never mix it into a full bottle of milk.
How often will my baby need blood tests for athyreosis?
In the first six months, your baby will typically need blood tests every 1 to 2 months. The frequency decreases as they grow, shifting to every 3 months between ages six months and three years.
What are the risks of incorrect levothyroxine doses in infants?
Under-treatment can lead to developmental delays, intellectual disabilities, and slowed growth. Over-treatment can cause poor sleep, heart strain, and long-term issues with bone density.
Can I give levothyroxine at the same time as soy formula?
No, you should not give levothyroxine at the same time as soy formula, iron supplements, or calcium drops. These specific foods and supplements can block the medication from being properly absorbed into your baby's bloodstream.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.What is the specific starting dose of levothyroxine you've chosen for my baby, and why?
  2. 2.Can you prescribe a liquid formulation of levothyroxine, or must we crush pills?
  3. 3.When exactly is our first follow-up blood test to check if the dose needs adjusting?
  4. 4.What signs of over-treatment or under-treatment should I look for at home?
  5. 5.Who should I contact if my baby spits up their medication right after taking it?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (11)
  1. 1

    Congenital Hypothyroidism: Screening and Management.

    Rose SR, Wassner AJ, Wintergerst KA, et al.

    Pediatrics 2023; (151(1)) doi:10.1542/peds.2022-060420.

    PMID: 36827521
  2. 2

    Congenital Hypothyroidism.

    Brady J, Cannupp A, Myers J, Jnah AJ

    Neonatal network : NN 2021; (40(6)):377-385 doi:10.1891/11-T-699.

    PMID: 34845088
  3. 3

    Clinical Insight into Congenital Hypothyroidism Among Children.

    Korkmaz HA

    Children (Basel, Switzerland) 2025; (12(1)) doi:10.3390/children12010055.

    PMID: 39857886
  4. 4

    Evaluation and management of the child with hypothyroidism.

    Leung AKC, Leung AAC

    World journal of pediatrics : WJP 2019; (15(2)):124-134 doi:10.1007/s12519-019-00230-w.

    PMID: 30734891
  5. 5

    TARGETED LEVOTHYROXINE THERAPY FOR TREATMENT OF CONGENITAL HYPOTHYROIDISM.

    Schoelwer MJ, Tu W, Zhou J, Eugster EA

    Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists 2017; (23(9)):1067-1071 doi:10.4158/EP171881.OR.

    PMID: 28683242
  6. 6

    Predictors of transient congenital primary hypothyroidism: data from the German registry for congenital hypothyroidism (AQUAPE "HypoDok").

    Matejek N, Tittel SR, Haberland H, et al.

    European journal of pediatrics 2021; (180(8)):2401-2408 doi:10.1007/s00431-021-04031-0.

    PMID: 33768331
  7. 7

    Primary Congenital Hypothyroidism in Children Below 3 Years Old - Etiology and Treatment With Overtreatment and Undertreatment Risks, a 5-Year Single Centre Experience.

    Lipska E, Lecka-Ambroziak A, Witkowski D, et al.

    Frontiers in endocrinology 2022; (13()):895507 doi:10.3389/fendo.2022.895507.

    PMID: 35832434
  8. 8

    Thyroid Hormone Suppression Therapy.

    Biondi B, Cooper DS

    Endocrinology and metabolism clinics of North America 2019; (48(1)):227-237 doi:10.1016/j.ecl.2018.10.008.

    PMID: 30717904
  9. 9

    Congenital Hypothyroidism: Screening and Management.

    Rose SR, Wassner AJ, Wintergerst KA, et al.

    Pediatrics 2023; (151(1)) doi:10.1542/peds.2022-060419.

    PMID: 36827523
  10. 10

    Newborn Screening Guidelines for Congenital Hypothyroidism in India: Recommendations of the Indian Society for Pediatric and Adolescent Endocrinology (ISPAE) - Part I: Screening and Confirmation of Diagnosis.

    Desai MP, Sharma R, Riaz I, et al.

    Indian journal of pediatrics 2018; (85(6)):440-447 doi:10.1007/s12098-017-2575-y.

    PMID: 29380252
  11. 11

    Congenital Hypothyroidism: A 2020-2021 Consensus Guidelines Update-An ENDO-European Reference Network Initiative Endorsed by the European Society for Pediatric Endocrinology and the European Society for Endocrinology.

    van Trotsenburg P, Stoupa A, Léger J, et al.

    Thyroid : official journal of the American Thyroid Association 2021; (31(3)):387-419 doi:10.1089/thy.2020.0333.

    PMID: 33272083

This page is for educational purposes and provides general information about athyreosis management in infants. Always consult your pediatric endocrinologist for specific dosage, medication administration, and blood test monitoring advice for your baby.

Get notified when new evidence is published on Athyreosis.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.